Monte Rosa Therapeutics GLUE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 7.41 | 108.98 | 18.94 | -0.33 | -32,975 | -27 |
| 2025Q2 | 4.51 | 140.18 | 45.09 | -0.15 | -15,554 | -12 |
| 2025Q1 | 4.64 | 92.31 | 0.57 | 44,036 | 47 | |
| 2024Q4 | 6.94 | 83.35 | 0.23 | 13,004 | 13 | |
| 2024Q3 | 5.30 | 111.51 | -0.26 | -26,527 | -24 | |
| 2024Q2 | 3.74 | 108.60 | -0.42 | -32,642 | -30 | |
| 2024Q1 | 7.05 | 109.60 | -0.53 | -34,947 | -32 | |
| 2023Q4 | 5.65 | 104.78 | -0.57 | -34,863 | -33 | |
| 2023Q3 | 4.79 | 106.49 | -0.70 | -36,968 | -35 | |
| 2023Q2 | 6.85 | 106.38 | -0.71 | -37,221 | -35 | |
| 2023Q1 | 7.79 | 106.93 | -0.65 | -34,259 | -32 | |
| 2022Q4 | 7.61 | 105.55 | -0.63 | -32,489 | -31 | |
| 2022Q3 | 8.17 | 103.82 | -0.59 | -28,362 | -27 | |
| 2022Q2 | 9.67 | 102.88 | -0.57 | -27,231 | -26 | |
| 2022Q1 | 14.02 | 101.55 | -0.51 | -24,302 | -24 | |
| 2021Q4 | 20.42 | 99.77 | -0.11 | -23,387 | -23 | |
| 2021Q3 | 22.28 | 100.16 | 6.18 | -19,868 | -20 | |
| 2021Q2 | 22.70 | 98.47 | -1.85 | -18,123 | -18 | |
| 2021Q1 | 93.71 | -7.18 | -11,504 | -12 | ||
| 2020Q4 | -11,936 | -20 |